U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07451613) titled 'Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease' on Feb. 08.
Brief Summary: The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Huntington Disease
Intervention:
BIOLOGICAL: hNSC-01
neural stem cell therapy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Leslie Thompson
Information provided by (Responsible Party): Leslie Thompson, University of California...